Among patients with epidermal growth factor receptor (EGFR)-mutant non-small cell lung cancer (NSCLC), Tagrisso (osimertinib) was associated with a higher incidence of cancer therapy-related cardiac ...

Fatigue (feeling very tired). Swelling and heaviness in the breast. Side effects can start months or years after treatment ends. These are called long-term or late effects. Late effects of breast ...

SAN FRANCISCO — Imagine a cancer ... treatment on lung and bladder tumors in mice. Not only did the treatment eliminate tumors, but it did so without causing the typical side-effects like ...